Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A role for the serotonin transporter in hypoxia-induced pulmonary hypertension
Barry L. Fanburg, Sheu-Ling Lee
Barry L. Fanburg, Sheu-Ling Lee
Published June 1, 2000
Citation Information: J Clin Invest. 2000;105(11):1521-1523. https://doi.org/10.1172/JCI10230.
View: Text | PDF
Commentary

A role for the serotonin transporter in hypoxia-induced pulmonary hypertension

  • Text
  • PDF
Abstract

Authors

Barry L. Fanburg, Sheu-Ling Lee

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Stimulation begins with contact between 5-HT and either a transporter or...
Stimulation begins with contact between 5-HT and either a transporter or receptor, which may lead to activation of Ras or Rac or both. The signal then activates a NAD(P)H oxidase that has not been fully characterized, leading to release of reactive oxygen species (ROS) and the activation of the ERK1 or ERK2 MAP kinases. The consequent changes in gene expression culminate in both cellular hyperplasia and hypertrophy.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts